View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Comment
May 9, 2019

Current Health gains FDA clearance for in-home remote patient monitoring

Current Health has US clearance for in-home monitoring of patients using its wearable device that remotely tracks an individual's vital signs.

By GlobalData

Edinburgh-based Current Health has received clearance from the US Food and Drug Administration (FDA ) for in-home monitoring of patients using its wearable device that remotely tracks an individual’s respiration, SP02 (oxygen saturation), pulse, temperature and movement.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

Vital signs medical devices

It is hoped the device will allow patients to experience reduced hospital stays and to return home earlier, as the device can monitor them from home and inform their healthcare provider remotely.

In-home monitoring can also enable earlier interventions, reduce hospital readmissions and help prevent avoidable deaths. In February 2019, the device received clearance from the FDA for monitoring patients in the hospital. Current Health has already partnered with healthcare providers, including Mount Sinai and Banner Health in the US and several NHS Trusts in the UK.

The device provides a passive single device that replaces multiple devices and eliminates the need for manual entry, reduces the need for spot measurements, and helps with low patient adherence. It has a chatbot for the patient and sends automated alerts to the healthcare provider based on an algorithmic analysis of the patients’ measured vitals via continuous, real-time wireless monitoring.

Current Health has received FDA approval for the RPM and telehealth platform. This system provides the patient with a tablet for the Bluetooth chatbot Q&A system. It also allows patients to connect to clinicians via video chat or text message to discuss their healthcare or report symptoms.

GlobalData believes that this is the future of medical devices and that the market for these devices will grow in the next few years as a result of new discoveries and research in this field.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network